Chandler's syndrome is a rare eye disorder in which the single layer of cells lining the interior of the cornea proliferates, causing changes within the iris, corneal swelling, and unusually high pressure in the eye (glaucoma). This condition is one of three syndromes, along with progressive iris atrophy and Cogan-Reese syndrome, that make up the iridocorneal endothelial (ICE) syndrome. In most cases, only one eye is affected. Symptoms may include reduced vision and pain. Chandler's syndrome more often affects females and usually presents sometime during middle age. The cause of this disease is unknown.
Last updated: 8/11/2014
How might Chandler's syndrome be treated?
While it is not possible to halt the progression of Chandler's syndrome, the glaucoma associated with this disease can be treated with medications and/or filtering surgery. Eye drops used in managing glaucoma decrease pressure in the eye by helping the eye's fluid drain more efficiently and/or decreasing the amount of fluid made by the eye.Drugs used to treat glaucoma are classified according to their active ingredient. These include prostaglandin analogs, beta blockers, alpha agonists, and carbonic anhydrase inhibitors. Combination drugs may be necessary for some patients. If these medications do not successfully treat the glaucoma, surgery may be indicated.Trabeculectomy may be used to treat glaucoma. In some cases, multiple procedures may be necessary. The corneal swelling associated with Chandler's syndrome may be treated through a cornea transplant. Further investigation is needed to determine the best way to manage this condition.
Last updated: 12/31/2014
Can Chandler's syndrome be treated with existing laser technology?
No. Existing laser therapy has not proven to be an effective treatment for Chandler's syndrome.
Last updated: 4/13/2010
If one eye is affected by Chandler's syndrome, is it possible for the other to become involved?
Most often, Chandler's syndrome affects only one eye. The other eye may have subclinical involvement (below the level required for diagnosis). In rare cases, both eyes may be clinically involved.
Last updated: 2/8/2012
We hope this information is helpful. We strongly recommend you discuss this information with your doctor. If you still have questions, please
Doe EA, Budenz DL, Gedde SJ, et al.. Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.. Ophthalmology. 2001; http://www.ncbi.nlm.nih.gov/pubmed/11581050. Accessed 12/31/2014.